Fig. 2From: Large-scale transcriptomic analysis reveals that pridopidine reverses aberrant gene expression and activates neuroprotective pathways in the YAC128 HD mousePridopidine reverses mouse YAC128 and human Huntington disease signatures. Pridopidine reversal of genes modulated in the YAC128 mouse model of Huntington disease (y-axis) as a function of human Huntington disease (x-axis). The blue dots represent 10 and 30Â mg/kg dose of pridopidineBack to article page